Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) EPS (Basic) (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of EPS (Basic) data on record, last reported at -$0.62 in Q4 2021.

  • For Q4 2021, EPS (Basic) rose 93.36% year-over-year to -$0.62; the TTM value through Dec 2021 reached -$1.87, up 88.44%, while the annual FY2025 figure was -$2.16, 11.34% down from the prior year.
  • EPS (Basic) reached -$0.62 in Q4 2021 per COGT's latest filing, down from -$0.48 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.07 in Q4 2019 and bottomed at -$9.34 in Q4 2020.
  • Average EPS (Basic) over 4 years is -$1.37, with a median of -$0.45 recorded in 2021.
  • Peak YoY movement for EPS (Basic): soared 125.93% in 2019, then tumbled 13442.86% in 2020.
  • A 4-year view of EPS (Basic) shows it stood at -$0.27 in 2018, then skyrocketed by 125.93% to $0.07 in 2019, then crashed by 13442.86% to -$9.34 in 2020, then skyrocketed by 93.36% to -$0.62 in 2021.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.62 in Q4 2021, -$0.48 in Q3 2021, and -$0.43 in Q2 2021.